Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07443800

Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia

Comorbidity Between Attention Deficit Hyperactivity Disorder (ADHD) and Fibromyalgia: Cross-prevalence in Patients Treated for ADHD Who Are naïve to Methylphenidate, ADHD Treated With Methylphenidate, or Fibromyalgia, and Associated Metabolomic Factors

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The overall objective of the research project presented here is to assess the prevalence of fibromyalgia in patients being treated for ADHD, the prevalence of ADHD in patients being treated for fibromyalgia, and the neurobiological correlates of ADHD-fibromyalgia comorbidity.

Conditions

Interventions

TypeNameDescription
OTHERSamples, questionnaires, assessment of pain and sensitivity to painBlood and urine samples including metabolomic analyses. Completing self-assessment questionnaires. Assessment of sensitivity to mechanical pain (by using the Von Frey monofilament test)

Timeline

Start date
2026-04-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2026-03-02
Last updated
2026-03-02

Source: ClinicalTrials.gov record NCT07443800. Inclusion in this directory is not an endorsement.

Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia (NCT07443800) · Clinical Trials Directory